Imagion Biosystems Ltd (IBX) — Cash Flow-to-Debt Ratio
Imagion Biosystems Ltd (IBX) has a Cash Flow-to-Debt Ratio of -0.54x as of December 2025, meaning its operating cash flow of AU$-2.27 Million could theoretically repay -1% of its total liabilities (AU$4.21 Million) in one year. See Imagion Biosystems Ltd (IBX) financial flexibility to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Imagion Biosystems Ltd Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Imagion Biosystems Ltd across 12 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Imagion Biosystems Ltd.
Annual Cash Flow-to-Debt Ratio for Imagion Biosystems Ltd (2014–2025)
Year-by-year debt coverage analysis for Imagion Biosystems Ltd. Check how high is Imagion Biosystems Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.96x | AU$-4.04 Million | AU$4.21 Million | ▼ -284.9% |
| 2024 | -0.25x | AU$-1.27 Million | AU$5.09 Million | ▲ +74.8% |
| 2023 | -0.99x | AU$-8.32 Million | AU$8.37 Million | ▲ +34.8% |
| 2022 | -1.52x | AU$-8.07 Million | AU$5.30 Million | ▲ +75.6% |
| 2021 | -6.26x | AU$-5.07 Million | AU$809.88K | ▼ -63.1% |
| 2020 | -3.84x | AU$-4.62 Million | AU$1.21 Million | ▼ -74.2% |
| 2019 | -2.20x | AU$-4.18 Million | AU$1.90 Million | ▲ +64.3% |
| 2018 | -6.17x | AU$-8.13 Million | AU$1.32 Million | ▲ +39.1% |
| 2017 | -10.13x | AU$-6.98 Million | AU$688.77K | ▼ -1613.3% |
| 2016 | -0.59x | AU$-267.26K | AU$451.99K | ▼ -35.1% |
| 2015 | -0.44x | AU$-4.22 Million | AU$9.65 Million | ▲ +22.4% |
| 2014 | -0.56x | AU$-2.43 Million | AU$4.31 Million | — |